Manipal Health Enterprises is set to make its stock market debut today, following an IPO that was subscribed 4.92 times overall. The IPO, open from July 29 to July 31, saw robust interest from Qualified Institutional Buyers (QIBs), with the segment subscribed 8.25 times, while retail investors subscribed 93% of their portion.
The public issue included a fresh issue of 13.56 crore equity shares worth Rs 8,000 crore and an Offer for Sale (OFS) of 2.16 crore shares valued at Rs 1,275.22 crore, totaling Rs 9,275.22 crore. The IPO was priced between Rs 560 and Rs 590 per share, with Kotak Mahindra Capital as the lead manager and KFin Technologies as the registrar.
Ahead of its listing, Manipal Health Enterprises shares are trading at a grey market premium (GMP) of Rs 3 over the upper issue price, suggesting a flat debut at approximately Rs 593 per share. While the GMP is a popular indicator of market sentiment, it remains unofficial and unregulated.
Founded in 2010, Manipal Health Enterprises has grown into a leading healthcare provider in India, operating 49 hospitals with 13,037 licensed beds and 21 clinics as of March 31, 2026. The company plans to use Rs 5,378 crore from the IPO proceeds for debt repayment and Rs 574 crore to acquire a minority stake in Sahyadri Hospitals.
As one of India's largest hospital operators, Manipal Health Enterprises' market debut is a significant event, reflecting investor sentiment toward the burgeoning healthcare sector in the country.
Background
Manipal Health Enterprises has expanded significantly since its founding in 2010, becoming a major player in India's healthcare industry. Its IPO is being closely watched as a barometer for the sector's growth potential and investor confidence.
Investors will be closely watching Manipal Health Enterprises' market performance, as it could set the tone for future IPOs in the healthcare sector. The company's strategic use of IPO proceeds to strengthen its balance sheet and fund expansion plans will be key areas of focus.
